We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Access to Adverse Event Data Focus of Updated EMA Policy
Access to Adverse Event Data Focus of Updated EMA Policy
The European Medicines Agency is updating its policy for accessing drug safety reports, bringing it in line with 2010 pharmacovigilance legislation that simplifies safety reporting and data sharing with non-EU authorities.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor